Product NDC: | 0024-1075 |
Proprietary Name: | Kayexalate |
Non Proprietary Name: | sodium polystyrene sulfonate |
Active Ingredient(s): | 4.1 meq/g & nbsp; sodium polystyrene sulfonate |
Administration Route(s): | ORAL; RECTAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-1075 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011287 |
Marketing Category: | NDA |
Start Marketing Date: | 19580108 |
Package NDC: | 0024-1075-01 |
Package Description: | 453.6 g in 1 JAR (0024-1075-01) |
NDC Code | 0024-1075-01 |
Proprietary Name | Kayexalate |
Package Description | 453.6 g in 1 JAR (0024-1075-01) |
Product NDC | 0024-1075 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sodium polystyrene sulfonate |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL; RECTAL |
Start Marketing Date | 19580108 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | SODIUM POLYSTYRENE SULFONATE |
Strength Number | 4.1 |
Strength Unit | meq/g |
Pharmaceutical Classes |